Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2011, Article ID 703676, 12 pages
http://dx.doi.org/10.1155/2011/703676
Research Article

Resveratrol Regulates Antioxidant Status, Inhibits Cytokine Expression and Restricts Apoptosis in Carbon Tetrachloride Induced Rat Hepatic Injury

1Department of Pharmaceutical Technology, NSHM Knowledge Campus, 124 B.L. Saha Road, Kolkata 700053, India
2Department of Pharmacology, Calcutta Institute of Pharmaceutical Technology and AHS, Howrah, Uluberia 711316, India
3Department of Pharmacology, Calcutta Medical College, West Bengal, Kolkata 700012, India

Received 31 May 2011; Revised 6 July 2011; Accepted 7 July 2011

Academic Editor: Ryuichi Morishita

Copyright © 2011 Souvik Roy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Wu, Q. Zhai, and X. Shi, “Alcohol-induced oxidative stress and cell responses,” Journal of Gastroenterology and Hepatology, vol. 21, no. 3, pp. S26–S29, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Loguercio and A. Federico, “Oxidative stress in viral and alcoholic hepatitis,” Free Radical Biology and Medicine, vol. 34, no. 1, pp. 1–10, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. I. F. Benzie, “Evolution of antioxidant defence mechanisms,” European Journal of Nutrition, vol. 39, no. 2, pp. 53–61, 2000. View at Google Scholar · View at Scopus
  4. H. Jaeschke, G. J. Gores, A. I. Cederbaum, J. A. Hinson, D. Pessayre, and J. J. Lemasters, “Mechanisms of hepatotoxicity,” Toxicological Sciences, vol. 65, no. 2, pp. 166–176, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. G. L. Plaa and M. Charbonneau, “Detection and evaluation of chemically induced liver injury,” in Principles and Methods of Toxicology, W. Hayes, Ed., pp. 1145–1178, Raven Press, New York, NY, USA, 2001. View at Google Scholar
  6. H. Tilg, “The role of cytokines in the pathophysiology of chronic liver diseases,” International Journal of Clinical and Laboratory Research, vol. 23, no. 4, pp. 179–185, 1993. View at Google Scholar · View at Scopus
  7. W. Dong, P. P. Simionova, R. Galluci et al., “Cytokine expression in hepatocytes: role of oxidant stress,” Journal of Interferon & Cytokine Research, vol. 18, pp. 629–638, 1998. View at Google Scholar
  8. D. McGregor and M. Lang, “Carbon tetrachloride: genetic effects and other modes of action,” Mutation Research, vol. 366, no. 3, pp. 181–195, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. L. J. Zhang, J. P. Yu, D. Li, and Y. H. Huang, “Effects of cytokines on carbon tetrachloride-induced hepatic fibrogenesis in rats,” World Journal of Gastroenterology, vol. 10, no. 1, pp. 77–81, 2004. View at Google Scholar · View at Scopus
  10. K. Kovalovich, R. A. Deangelis, W. Li, E. E. Furth, G. Ciliberto, and R. Taub, “Increased toxin-induced liver injury and fibrosis in interleukin-6- deficient mice,” Hepatology, vol. 31, no. 1, pp. 149–159, 2000. View at Google Scholar · View at Scopus
  11. M. I. Luster, P. P. Simeonova, R. Gallucci, and J. Matheson, “Tumor necrosis factor α and toxicology,” Critical Reviews in Toxicology, vol. 29, no. 5, pp. 491–511, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. J. K. Kundu and Y. J. Surh, “Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives,” Cancer Letters, vol. 269, no. 2, pp. 243–261, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. C. D. Venturini, S. Merlo, A. A. Souto, M. C. Fernandes, R. Gomez, and C. R. Rhoden, “Resveratrol and red wine function as antioxidants in the central nervous system without cellular proliferative effects during experimental diabetes,” Oxidative Medicine and Cellular Longevity, vol. 3, no. 6, pp. 434–441, 2010. View at Google Scholar
  14. P. Kovacic and R. Somanathan, “Multifaceted approach to resveratrol bioactivity: focus on antioxidant action, cell signaling and safety,” Oxidative Medicine and Cellular Longevity, vol. 3, no. 2, pp. 86–100, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Palsamy and S. Subramanian, “Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats,” Chemico-Biological Interactions, vol. 179, no. 2-3, pp. 356–362, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Lee, S. Kim, O. K. Kwon, S. R. Oh, H. K. Lee, and K. Ahn, “Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma,” International Immunopharmacology, vol. 9, no. 4, pp. 418–424, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Luna, G. Li, P. B. Liton et al., “Resveratrol prevents the expression of glaucoma markers induced by chronic oxidative stress in trabecular meshwork cells,” Food and Chemical Toxicology, vol. 47, no. 1, pp. 198–204, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. D. Li, Q. Y. Ma, and C. A. Wang, “Effect of resveratrol on pancreatic oxygen free radicals in rats with severe acute pancreatitis,” World Journal of Gastroenterology, vol. 12, no. 1, pp. 137–140, 2006. View at Google Scholar · View at Scopus
  19. M. Shakibaei, C. Csaki, S. Nebrich, and A. Mobasheri, “Resveratrol suppresses interleukin-1β-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis,” Biochemical Pharmacology, vol. 76, no. 11, pp. 1426–1439, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. D. K. Das and N. Maulik, “Resveratrol in cardioprotection: a therapeutic promise of alternative medicine,” Molecular Interventions, vol. 6, no. 1, pp. 36–47, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. A. K. Grissa, B. Mornagui, E. Aouani et al., “Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver,” Life Sciences, vol. 80, no. 11, pp. 1033–1039, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Cerna, D. Kotyzova, and V. Eybl, “Protective effect of resveratrol in acute liver damage in rats,” Toxicology Letters, vol. 180, pp. 32–246, 2008. View at Google Scholar
  23. S. H. Khabbar, C. H. Cottart, D. Wendum et al., “Postischemic treatment by trans-resveratrol in rat liver ischemia-reperfusion: a possible strategy in liver surgery,” Liver Transplantation, vol. 14, no. 4, pp. 451–459, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. F. Marier, K. Chen, P. Prince, G. Scott, J. R. E. del Castillo, and P. Vachon, “Production of ex vivo lipopolysaccharide-induced tumor necrosis factor-α, interleukin-1β, and interleukin-6 is suppressed by trans-resveratrol in a concentration-dependent manner,” Canadian Journal of Veterinary Research, vol. 69, no. 2, pp. 151–154, 2005. View at Google Scholar · View at Scopus
  25. L. Ravagnan, T. Roumier, and G. Kroemer, “Mitochondria, the killer organelles and their weapons,” Journal of Cellular Physiology, vol. 192, no. 2, pp. 131–137, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Zhang, M. Dong, L. Li et al., “Endonuclease G is required for early embryogenesis and normal apoptosis in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 26, pp. 15782–15787, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Chen, Z. Yang, and F. Qiu, “Studies on hepatocyte apoptosis, proliferation and oncogene c-fos expression in carbon tetrachloride-induced cirrhotic rat liver,” Journal of Tongji Medical University, vol. 19, no. 1, pp. 53–55, 1999. View at Google Scholar · View at Scopus
  28. M. L. Berger, H. Bhatt, B. Combes, and R. W. Estabrook, “CCl4-induced toxicity in isolated hepatocytes: the importance of direct solvent injury,” Hepatology, vol. 6, no. 1, pp. 36–45, 1986. View at Google Scholar · View at Scopus
  29. M. Leist, F. Gantner, H. Naumann et al., “Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins,” Gastroenterology, vol. 112, no. 3, pp. 923–934, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. J. M. Hwang, T. H. Tseng, Y. S. Hsieh, F. P. Chou, C. J. Wang, and C. Y. Chu, “Inhibitory effect of atractylon on tert-butyl hydroperoxide induced DNA damage and hepatic toxicity in rat hepatocytes,” Archives of Toxicology, vol. 70, no. 10, pp. 640–644, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Luper, “A review of plants used in the treatment of liver disease: part 1,” Alternative Medicine Review, vol. 3, no. 6, pp. 410–421, 1998. View at Google Scholar · View at Scopus
  32. K. V. Pugalendi and T. Radhiga, “Potential beneficial effect of protocatechuic acid on hepatic markers, lipid peroxidation and antioxidant status against D-Galactosamine induced toxicity in rats,” Pharmaceutical Research, vol. 4, pp. 222–225, 2011. View at Google Scholar
  33. J. A. Brent and B. H. Rumack, “Role of free radicals in toxic hepatic injury. II. Are free radicals the cause of toxin-induced liver injury?” Journal of Toxicology—Clinical Toxicology, vol. 31, no. 1, pp. 173–196, 1993. View at Google Scholar · View at Scopus
  34. N. Brautbar and J. Williams, “Industrial solvents and liver toxicity: risk assessment, risk factors and mechanisms,” International Journal of Hygiene and Environmental Health, vol. 205, no. 6, pp. 479–491, 2002. View at Google Scholar · View at Scopus
  35. M. K. Manibusan, M. Odin, and D. A. Eastmond, “Postulated carbon tetrachloride mode of action: a review,” Journal of Environmental Science and Health: Part C, vol. 25, pp. 185–209, 2007. View at Google Scholar
  36. H. Rivera, M. Shibayama, V. Tsutsumi, V. Perez-Alvarez, and P. Muriel, “Resveratrol and trimethylated resveratrol protect from acute liver damage induced by CCI4 in the rat,” Journal of Applied Toxicology, vol. 28, no. 2, pp. 147–155, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Chávez, K. Reyes-Gordillo, J. Segovia et al., “Resveratrol prevents fibrosis, NF-κB activation and TGF-β increases induced by chronic CCl4 treatment in rats,” Journal of Applied Toxicology, vol. 28, no. 1, pp. 35–43, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. R. O. Recknagel, E. A. Glende Jr., and R. S. Briton, “Free radical damage and lipid peroxidation,” in Hepatotoxicology, R. G. Meeks, Ed., pp. 401–436, CRC Press, Florida, Fla, USA, 1991. View at Google Scholar
  39. A. T. Williams and R. F. Burk, “Carbon tetrachloride hepatotoxicity: an example of free radical-mediated injury,” Seminars in Liver Disease, vol. 10, no. 4, pp. 279–284, 1990. View at Google Scholar · View at Scopus
  40. T. D. Boyer, D. A. Vessey, C. Holcomb, and N. Saley, “Studies of the relationship between the catalytic activity and binding of non-substrate ligands by the glutathione S-transferases,” Biochemical Journal, vol. 217, no. 1, pp. 179–185, 1984. View at Google Scholar · View at Scopus
  41. J. A. Rubiolo and F. V. Vega, “Resveratrol protects primary rat hepatocytes against necrosis induced by reactive oxygen species,” Biomedicine and Pharmacotherapy, vol. 62, no. 9, pp. 606–612, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Hernandez-Munoz, P. De la Torre, J. A. Sanchez-Alcazar et al., “Tumor necrosis factor α inhibits collagen α1(I) gene expression in rat hepatic stellate cells through a G protein,” Gastroenterology, vol. 113, no. 2, pp. 625–640, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Vanden Berghe, G. Denecker, G. Brouckaert, D. Vadimovisch Krysko, K. D'Herde, and P. Vandenabeele, “More than one way to die: methods to determine TNF-induced apoptosis and necrosis,” Methods in Molecular Medicine, vol. 98, pp. 101–126, 2004. View at Google Scholar · View at Scopus
  44. D. E. Cressman, L. E. Greenbaum, R. A. DeAngelis et al., “Liver failure and defective hepatocyte regeneration in interleukin-6- deficient mice,” Science, vol. 274, no. 5291, pp. 1379–1383, 1996. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Tsujimura, F. Ichinose, T. Hara, K. Yamasaki, M. Otsuka, and S. Fukushima, “The inhalation exposure of carbon tetrachloride promote rat liver carcinogenesis in a medium-term liver bioassay,” Toxicology Letters, vol. 176, no. 3, pp. 207–214, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Bishayee and N. Dhir, “Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis,” Chemico-Biological Interactions, vol. 179, no. 2-3, pp. 131–144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. K. J. Lee and H. G. Jeong, “Protective effect of Platycodi radix on carbon tetrachloride-induced hepatotoxicity,” Food and Chemical Toxicology, vol. 40, no. 4, pp. 517–525, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. K. J. Lee, E. R. Woo, C. Y. Choi et al., “Protective effect of acteoside on carbon tetrachloride induced hepatotoxicity,” Life Sciences, vol. 74, no. 8, pp. 1051–1064, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. W. H. Habig, M. J. Pabst, and W. B. Jakoby, “Glutathione S transferases. The first enzymatic step in mercapturic acid formation,” Journal of Biological Chemistry, vol. 249, no. 22, pp. 7130–7139, 1974. View at Google Scholar · View at Scopus